Copyright
©The Author(s) 2021.
World J Gastrointest Oncol. Jul 15, 2021; 13(7): 693-705
Published online Jul 15, 2021. doi: 10.4251/wjgo.v13.i7.693
Published online Jul 15, 2021. doi: 10.4251/wjgo.v13.i7.693
Figure 1 Cryptotanshinone suppresses the proliferation of gastric cancer cells.
A: The chemical structure of cryptotanshinone (CTS); B: MGC-803 cells were treated with the indicated doses of CTS for 48 h, and cell growth was detected by the Cell Counting Kit-8 (CCK-8) assay; C: MGC-803 cells were treated with 10 μmol/L CTS for 0–72 h, and cell growth was detected by the CCK-8 assay. Data are expressed as the mean ± SD from triplicate experiments. aP < 0.05; bP < 0.01.
- Citation: Chen ZM, Hu J, Xu YM, He W, Meng L, Huang T, Ying SC, Jiang Z, Xu AM. Cryptotanshinone inhibits cytotoxin-associated gene A-associated development of gastric cancer and mucosal erosions. World J Gastrointest Oncol 2021; 13(7): 693-705
- URL: https://www.wjgnet.com/1948-5204/full/v13/i7/693.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v13.i7.693